MAPT and Alzheimer disease: One study reported that combining Fazekas grading with other biomarkers, such as beta-amyloid and tau proteins in cerebrospinal fluid, resulted in a higher diagnostic accuracy for Alzheimer’s disease than using Fazekas grading alone (47).